You have 9 free searches left this month | for more free features.

Symptomatic myeloma

Showing 1 - 25 of 7,077

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Multiple Myeloma Trial (Linvoseltamab)

Not yet recruiting
  • Multiple Myeloma
  • (no location specified)
Apr 12, 2023

Recurrent Plasma Cell Myeloma Trial in Jacksonville (Dexamethasone, Laboratory Biomarker Analysis, Lenalidomide)

Active, not recruiting
  • Recurrent Plasma Cell Myeloma
  • Jacksonville, Florida
    Mayo Clinic in Florida
Jan 4, 2023

Biology and Genetics of Smouldering Myeloma

Recruiting
  • Smouldering Myeloma
  • +2 more
  • No intervention
  • London, United Kingdom
    University College London Hospitals
Sep 15, 2021

Myeloma Trial in France (18F-Fludarabine)

Not yet recruiting
  • Myeloma
  • Angers, France
  • +6 more
Dec 24, 2021

Multiple Myeloma Trial in Nantes ([68Ga]Ga-PentixaFor)

Recruiting
  • Multiple Myeloma
  • Nantes, France
    Nantes UH
Sep 24, 2021

People With Multiple Myeloma in Portugal

Recruiting
  • Relapse and/or Refractory Multiple Myeloma
    • Braga, Portugal
    • +7 more
    Jun 9, 2022

    Bone Pain, Metastatic Malignant Tumor in the Bone, Plasma Cell Myeloma Trial in United States (Quality-of-Life Assessment,

    Recruiting
    • Bone Pain
    • +2 more
    • Quality-of-Life Assessment
    • +2 more
    • Duarte, California
    • +7 more
    Feb 25, 2022

    Smoldering Multiple Myeloma Trial in Spain (carfilzomib, Lenalidomide, Dexamethasone)

    Active, not recruiting
    • Smoldering Multiple Myeloma
    • Barcelona, Spain
    • +15 more
    Feb 15, 2021

    Primary Systemic Amyloidosis, Light Chain Deposition Disease Trial in United States (drug, genetic, other, procedure)

    Active, not recruiting
    • Primary Systemic Amyloidosis
    • Light Chain Deposition Disease
    • Denver, Colorado
    • +6 more
    Aug 24, 2022

    Biological Relapse in Patients With Multiple Myeloma

    Terminated
    • Multiple Myeloma
      • Zaragoza, Aragón, Spain
      • +43 more
      Sep 7, 2021

      Multiple Myeloma Trial in Germany (Bendamustine, Bortezomib, Prednisone)

      Completed
      • Multiple Myeloma
      • Bendamustine, Bortezomib, Prednisone
      • Mannheim, Ba-Wü, Germany
      • +14 more
      Oct 14, 2020

      Multiple Myeloma Trial in United Kingdom (Autologous Stem Cell Transplant (ASCT), Consolidation with 4 cycles of CarCyDex)

      Active, not recruiting
      • Multiple Myeloma
      • Autologous Stem Cell Transplant (ASCT)
      • Consolidation with 4 cycles of CarCyDex
      • Romford, Essex, United Kingdom
      • +19 more
      May 4, 2021

      Multiple Myeloma Symptomatic Relapse and/or Refractory Disease

      Completed
      • Multiple Myeloma
      • No Intervention
      • Cadiz, Andalucia, Spain
      • +29 more
      Sep 14, 2020

      Smoldering Multiple Myeloma Trial (Selinexor)

      Not yet recruiting
      • Smoldering Multiple Myeloma
      • (no location specified)
      Oct 27, 2022

      Multiple Myeloma Trial in Austria, Germany, Israel (Denosumab 120 MG/1.7 ML Subcutaneous Solution [XGEVA], Placebo 1.7 ml

      Active, not recruiting
      • Multiple Myeloma
      • Denosumab 120 MG/1.7 ML Subcutaneous Solution [XGEVA]
      • Placebo 1.7 ml Subcutaneous Solution
      • Graz, Austria
      • +9 more
      Aug 24, 2022

      Multiple Myeloma Trial in France (Carfilzomib)

      Unknown status
      • Multiple Myeloma
      • Avignon, France
      • +32 more
      Aug 26, 2020

      Developing Myeloma in a High-Risk Screened Population (PROMISE)

      Recruiting
      • Multiple Myeloma
      • Sample of Blood
      • Baltimore, Maryland
      • +2 more
      Mar 22, 2022

      Biomarker for Infection Risk in CLL and MM

      Not yet recruiting
      • Multiple Myeloma
      • Chronic Lymphocytic Leukemia
      • Screening
      • Boston, Massachusetts
        Massachusetts General Hospital Cancer Center
      May 3, 2023

      Multiple Myeloma, Myeloma-Associated Amyloidosis Trial in Saint Louis (Selinexor, Lenalidomide, Dexamethasone)

      Not yet recruiting
      • Multiple Myeloma
      • Myeloma-Associated Amyloidosis
      • Saint Louis, Missouri
        Washington University School of Medicine
      Apr 6, 2023

      Multiple Myeloma and Plasma Cell Tumor Trial in Rochester (dexamethasone, lenalidomide)

      Completed
      • Multiple Myeloma and Plasma Cell Neoplasm
      • Rochester, Minnesota
        Mayo Clinic
      Jan 9, 2020

      Multiple Myeloma Trial in Miami (Teclistamab, Talquetamab, Daratumumab SC)

      Not yet recruiting
      • Multiple Myeloma
      • Miami, Florida
        University of Miami
      Oct 20, 2023

      MDS, Multiple Myeloma, Anemia Trial in France, Italy, United States (INCB000928)

      Recruiting
      • Myelodysplastic Syndromes
      • +2 more
      • Palo Alto, California
      • +13 more
      Dec 12, 2022

      Multiple Myeloma Trial in Denmark, Estonia, Norway (Selinexor 20 MG Oral Tablet, Bortezomib Injection, Lenalidomide capsule)

      Recruiting
      • Multiple Myeloma
      • Selinexor 20 MG Oral Tablet
      • +3 more
      • Aalborg, Denmark
      • +10 more
      Apr 22, 2022

      Multiple Myeloma Trial run by the National Cancer Institute (NCI) (Dexamethasone, Carfilzomib, Daratumumab)

      Recruiting
      • Multiple Myeloma
      • Bethesda, Maryland
        National Institutes of Health Clinical Center
      Jan 23, 2023

      Multiple Myeloma Trial in Vitoria-Gasteiz (Bortezomib, Melphalan, Prednisone)

      Terminated
      • Multiple Myeloma
      • Vitoria-Gasteiz, Araba, Spain
        Araba of University Hospital
      Jan 14, 2020